<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220427054675N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-01-19</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>comparison of gate adaptability and symmetry outcomes between immediate post-operative prosthesis and classic methods in lower limb amputees</public_title>
      <acronym>IPOP</acronym>
      <scientific_title>comparison of gate adaptability and symmetry outcomes between immediate post-operative prosthesis and classic methods in lower limb amputees</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-03-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>98</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63332</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: this research is a simple randomized controlled trial that random number tables are used before starting the research. even numbers are used for group A (interventional group) and odd numbers are used for group B (control group). To avoid disparity between group sizes, we used replacement randomization. If the disparity exceeded the preset criterion of the study sample size, we generated another randomization list using simple randomization until we achieved a balanced group size, Blinding description: in this study patient could not blinded. doctors and all health providers could not be blinded neither because they are present at the surgery and post-surgery cares. but on the other hand all researchers and laboratory technicians and data analyzers all fully blinded. during musculoskeletal assessments all of the patients are wearing permanent prosthesis which give no information about the post-operative rehabilitation methods. In data extraction period all the subjects names are coded and no information about medical history of patients are provided for analyzers. To prevent revealing verbal communication between the evaluator and the patient, an observer (who does not have any information) will be present at the evaluation site.</study_design>
      <phase>N/A</phase>
      <hc_freetext>trans-tibial (below knee) amputation.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this group patients receive immediate post-operative prosthesis as a recovery and rehabilitation method. The immediate prosthesis has a thermoplastic socket, which is padded with 4 mm polyfoam. The volume of the socket can be adjusted through four straps. The patient uses this prosthesis for one month after surgery. In the first 3 days, stretching exercises are done to strengthen the muscles. In the next 3 to 5 days, standing exercises are performed with the application of limited weight (10 pounds on the first day and its gradual increase in the following days to a maximum of half the body weight) (a scale is placed under the patient's foot to accurately apply the amount of pressure). After this course, walking exercises will be done with a walker. Intervention 2: Control group: In this group patients receive classic methods (soft bandage). For these participants, the stitched area is covered with a soft bandage, and only exercises to strengthen the muscles of the arms and legs are provided to the person in a lying and sitting position.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
gait parameters Data

When:
1402-1403

To whom:
academic faculty

Conditions:
retrospective studies

Where to obtain:
writers- email

How to obtain:
sending an email including research project documents

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Taghziadeh Herat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>no1 ansari alley qeitarieh street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1938953130</zip>
        <telephone>+98 21 2267 1440</telephone>
        <email>zahrataghizadehherat@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>seyed mahmoud mousavi ziarati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>south JanatAbad st.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1474667168</zip>
        <telephone>+98 21 4444 8552</telephone>
        <email>mousavi2m@outlook.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>trans-tibial(below knee) amputee
informed consents of patient for entering the research
age between 18 to 80</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>k2 activity level and below
lower limb bilateral amputation
cognition disorder
upper limb amputation
No Light Perception (NLP)
skin graft
muscle contracture
any other musculoskeletal disease that makes the walking by prothesis impossible
soft tissue low quality that we concern about the wound remission</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z89.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Acquired absence of leg below knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this group patients receive immediate post-operative prosthesis as a recovery and rehabilitation method. The immediate prosthesis has a thermoplastic socket, which is padded with 4 mm polyfoam. The volume of the socket can be adjusted through four straps. The patient uses this prosthesis for one month after surgery. In the first 3 days, stretching exercises are done to strengthen the muscles. In the next 3 to 5 days, standing exercises are performed with the application of limited weight (10 pounds on the first day and its gradual increase in the following days to a maximum of half the body weight) (a scale is placed under the patient's foot to accurately apply the amount of pressure). After this course, walking exercises will be done with a walker.</i_keyword>
      <i_keyword>Control group: In this group patients receive classic methods (soft bandage). For these participants, the stitched area is covered with a soft bandage, and only exercises to strengthen the muscles of the arms and legs are provided to the person in a lying and sitting position.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Gait symmetry. Timepoint: 1, 6, and 12 months after permanent prosthesis application. Method of measurement: measuring of differences between lower limbs stride length, time, and speed.</prim_outcome>
      <prim_outcome>Gait adaptability. Timepoint: 1, 6, and 12 months after permanent prosthesis application. Method of measurement: 1. gait adaptability measurement is done in such a way that a laser line is displayed on the ground one step before the patient arrives and the person must be able to cross it.  2. The ability to cross the obstacle in such a way that one step before the patient arrives A plastic barrier with a height of 15 cm appears and the person must be able to pass through it.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-09-11</approval_date>
        <contact_name>shahidbeheshti university of medical science</contact_name>
        <contact_address>velenjak daneshjoo street medicine school tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
